tissue microarray

NEW YORK (GenomeWeb News) – Nuclea Biotechnologies today announced the acquisition of a portfolio of six patents and applications related to tissue microarrays for an undisclosed amount.

Visiopharm and Integrated Systems Engineering have agreed to comarket their products to researchers using tissue microarrays.

By Justin Petrone
The National Institutes of Health is looking for a partner to commercialize a new tissue microarrayer that its inventor claims could cost one-tenth the price of similar instruments on the market.

The Karmanos Cancer Institute will use Definiens' Tissue Studio 2.0 digital pathology software to automate tissue section and microarray analysis.

Metamark disclosed last week in a filing with the US Securities and Exchange Commission that it raised about $22 million in a Series B round of financing. The company is targeting about $42 million in total.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.